Status:

COMPLETED

Permanent Cerebral Oxymetry Monitoring for Early Diagnosis and Treatment of Delayed Vasospasm After Subarachnoid Hemorrhage

Lead Sponsor:

University Hospital, Bordeaux

Conditions:

Subarachnoid Hemorrhage

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Transcranial Doppler ultrasound (TCD) monitoring and CT-scanner perfusion are useful but imperfect tools to identify vasospasm and allow intervention to avoid infarction. Permanent monitoring of cere...

Detailed Description

Delayed vasospasm is a serious complication of aneurismal subarachnoid haemorhage (SAH) significantly influencing morbidity and mortality. Mostly observed between days 4 and 10 after aneurismal ruptur...

Eligibility Criteria

Inclusion

  • Men and women
  • Age ≥ 18 years
  • HSA of aneurysmal etiology less than 4 days before inclusion diagnosed by clinical presentation and emergency imaging
  • HSA "severe" defined according to the WFNS ≥ III
  • Intubated-ventilated patient or any other reason preventing a contributing neurological examination
  • Affiliate or beneficiary of a social security scheme
  • Free, informed and written consent signed by the representative

Exclusion

  • Age \<18 years
  • Significant vasospasm as soon as the detection was detected on the initial imaging
  • Possible Neurological Surveillance
  • Patient in limitation of active therapeutics or with high probability of soon limitation of active therapeutics
  • Intra-parenchymal frontal haematoma limiting the quality of measurement, diagnosed on imaging (Less than 25mm deep from the skin)
  • Patient in limitation of active therapeutics or with high probability of soon limitation of active therapeutics
  • Adhesive allergy to measuring patches
  • Patient under guardianship or safeguard of justice
  • Refusal of legal representative

Key Trial Info

Start Date :

October 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 30 2022

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04042571

Start Date

October 1 2019

End Date

December 30 2022

Last Update

July 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU de Bordeaux

Bordeaux, France, 33 076